Scientists test Next-Generation shot in quest for HIV vaccine
NCT ID NCT04915768
Summary
This early-stage study tested a new experimental HIV vaccine in 51 healthy, HIV-negative adults. The main goals were to check if the vaccine was safe and to see if it could stimulate the immune system to produce antibodies that might fight HIV. Researchers tested different doses and combinations of vaccine ingredients to find the best formula for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's CRS
Boston, Massachusetts, 02115, United States
-
The Hope Clinic of the Emory Vaccine Center CRS
Decatur, Georgia, 30030, United States
-
Vanderbilt Vaccine (VV) CRS
Nashville, Tennessee, 30030, United States
Conditions
Explore the condition pages connected to this study.